Falma Laboratories Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 1985.
1985 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Falma Laboratories Private Limited

Falma Laboratories Private Limited, a active private limited company, was established on 05 December 1985 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230KA1985PTC007328. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 M.

It upholds a active non-compliant status. Its leadership includes Kollenmareth Oomman Isaac (Director), Prabir Kumar Sarkar (Additional Director), Subhas Banerjee (Additional Director). Past directors included Saramma Mathai, Rakesh Binaykia, Kollenmareth Oomman Isaac. It holds no open charges and ₹1.30 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at No. 37/A2, Pillagumpe Industrial Area, Hoskote, Bangalore, Karnataka, 562114.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KA1985PTC007328

  • Registration Number

    007328

  • Incorporation Date

    05 December 1985

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹3.00 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 3.00 M
  • Company Age 40 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.30 Cr
  • Revenue Growth **** -17.15%
  • Profit Growth **** 56.07%
  • Ebitda **** 44.67%
  • Net Worth -0.05%
  • Total Assets **** 0.02%
Company report

Falma Laboratories Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Falma Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Falma Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Kollenmareth Oomman Isaac Director 21 Jun 2012 Current
Prabir Kumar Sarkar Additional Director 05 Aug 2013 Current
Subhas Banerjee Additional Director 01 Jul 2015 Current
Subrata Dasgupta Additional Director 15 May 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Jul 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2010 Past
Pramod Abcsdd Director 31 Mar 2014 Past
Pramod Abcsdd Additional Director 15 May 2019 Past
Pramod Abcsdd Additional Director 01 Jul 2015 Past
Pramod Abcsdd Director 25 Mar 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Falma Laboratories.

Falma Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 17.15% decrease. The company also saw a substantial improvement in profitability, with a 56.07% increase in profit. The company's net worth dipped by a decrease of 0.05%.

Falma Laboratories revenue growth over time
Falma Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -17.15%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 0.02%
*******
*******
*******
*******
Profit or Loss
*******
 56.07%
*******
*******
*******
*******
Net Worth
*******
 -0.05%
*******
*******
*******
*******
EBITDA
*******
 44.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Falma Laboratories?

In 2020, Falma Laboratories had a promoter holding of 67.79% and a public holding of 32.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹12,980,000.00

Charges Breakdown by Lending Institutions
  • Karnataka State Financial Corporation : 1.07 Cr
  • Karnataka State Finance Corporation : 0.23 Cr
Latest Charge Details
Date Lender Amount Status
15 Mar 1995 Karnataka State Financial Corporation ₹4.68 M Satisfied
30 Apr 1994 Karnataka State Finance Corporation ₹2.30 M Satisfied
14 May 1988 Karnataka State Financial Corporation ₹1.15 M Satisfied
10 Aug 1987 Karnataka State Financial Corporation ₹4.85 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Falma Laboratories?

Falma Laboratories has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Falma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Falma Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Falma Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    Falma Laboratories Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Falma Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    Subrata Dasgupta was appointed as a Additional Director was appointed as a Additional Director on 15 May 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.

  • Director Appointment

    Subhas Banerjee was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Prabir Kumar Sarkar was appointed as a Additional Director was appointed as a Additional Director on 05 Aug 2013 & has been associated with this company since 12 years 6 months . was completed.

  • Director Appointment

    The activity Kollenmareth Oomman Isaac was appointed as a Director was appointed as a Director on 21 Jun 2012 & has been associated with this company since 13 years 7 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Falma Laboratories Private Limited?

The CIN of Falma Laboratories Private Limited is U24230KA1985PTC007328.

Where is Falma Laboratories Private Limited headquartered?

Falma Laboratories Private Limited is headquartered at No. 37/A2, Pillagumpe Industrial Area, Hoskote, Bangalore, Karnataka, 562114.

When was Falma Laboratories Private Limited incorporated?

Falma Laboratories Private Limited was incorporated on 05 December 1985.

Who are the current directors of Falma Laboratories Private Limited?

The current directors of Falma Laboratories Private Limited are

What is the primary industry of Falma Laboratories Private Limited?

The primary industry of Falma Laboratories Private Limited is Pharma.

Is Falma Laboratories Private Limited a listed company?

Falma Laboratories Private Limited is unlisted.

What is the capital structure of Falma Laboratories Private Limited?

The authorized capital of Falma Laboratories Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 M.

What is the compliance status of Falma Laboratories Private Limited?

The compliance status of Falma Laboratories Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available